Your browser doesn't support javascript.
loading
A distinct innate immune signature marks progression from mild to severe COVID-19.
Chevrier, Stéphane; Zurbuchen, Yves; Cervia, Carlo; Adamo, Sarah; Raeber, Miro E; de Souza, Natalie; Sivapatham, Sujana; Jacobs, Andrea; Bachli, Esther; Rudiger, Alain; Stüssi-Helbling, Melina; Huber, Lars C; Schaer, Dominik J; Nilsson, Jakob; Boyman, Onur; Bodenmiller, Bernd.
Afiliación
  • Chevrier S; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
  • Zurbuchen Y; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Cervia C; Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland.
  • Adamo S; Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland.
  • Raeber ME; Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland.
  • de Souza N; Department of Immunology, University Hospital Zurich (USZ), Zurich, Switzerland.
  • Sivapatham S; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
  • Jacobs A; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Bachli E; Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
  • Rudiger A; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
  • Stüssi-Helbling M; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Huber LC; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
  • Schaer DJ; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Nilsson J; Clinic for Internal Medicine, Uster Hospital, Uster, Switzerland.
  • Boyman O; Department of Medicine, Limmattal Hospital, Schlieren, Switzerland.
  • Bodenmiller B; Clinic for Internal Medicine, City Hospital Triemli Zurich, Zurich, Switzerland.
Cell Rep Med ; 2(1): 100166, 2021 01 19.
Article en En | MEDLINE | ID: mdl-33521697

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Inmunidad Innata Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Inmunidad Innata Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Suiza